|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 285/24 | (2006.01) |
| C07D 249/12 | (2006.01) | ||
| A01N 37/44 | (2006.01) | ||
| A61P 3/00 | (2006.01) |
| (11) | Number of the document | 2714669 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12789268.5 |
| Date of filing the European patent application | 2012-05-22 | |
| (97) | Date of publication of the European application | 2014-04-09 |
| (45) | Date of publication and mention of the grant of the patent | 2017-04-26 |
| (46) | Date of publication of the claims translation | 2017-08-10 |
| (86) | Number | PCT/US2012/039011 |
| Date | 2012-05-22 |
| (87) | Number | WO 2012/162323 |
| Date | 2012-11-29 |
| (30) | Number | Date | Country code |
| 201161489597 P | 2011-05-24 | US |
| (72) |
MINER, Jeffrey, US
|
| (73) |
Ardea Biosciences, Inc.,
9390 Towne Centre Drive, San Diego CA 92121,
US
|
| (74) |
Liucija JANICKAITĖ,
Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius,
LT
|
| (54) | Hipertenzija ir hiperurikemija |
| HYPERTENSION AND HYPERURICEMIA |
| Payment date | Validity (years) | Amount | |
| 2019-05-02 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-05-22 |